Received: 27 February 2020
Accepted: 10 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: All study protocol and procedures were reviewed and approved by the Mayo Clinic Institutional Review Board (IRB) (study # 15–001876). The study was deemed as “minimal risk”. All participants in this study met with a research team member and received written and oral information; it included explaining the study intent, their participation in the study, and the complete autonomy to volunteer and participate in this study as well as their ability to withdraw from it without questions asked and at any time. Participants were given ample time to ask, discuss, and reflect on any questions before providing their consent to participate. Participating patients provided written consent while participating caregivers and clinicians provided oral consent. All participants received copy of the consent forms, including institutional and investigator’s contact information for any future communication or inquiry. All consent forms, consenting approaches, and study protocols were thoroughly reviewed and approved by the Mayo Clinic IRB.
: Not applicable.
: No conflict of or competing interests reported for all authors.